OPHTHALMOLOGY MANAGEMENT NAMES NEW CHIEF MEDICAL EDITOR

Lisa K. Feulner, MD, PhD, will assume the role at the start of 2022.

Ophthalmology Management announces the appointment of Lisa K. Feulner, MD, PhD, as its new chief medical editor, starting with the publication’s January 2022 issue. Dr. Feulner succeeds Larry E. Patterson, MD, who will step down after 13 years as Ophthalmology Management’s chief medical editor.

“I’d like to thank Dr. Patterson for his guidance and insight during the last 13 years, which have helped catapult Ophthalmology Management into the number one position in market share,” says Douglas A. Parry, executive vice president and publisher of Ophthalmology Management. “His pointed editorials have been the best in the field, done with wit, humor and always thought-provoking.”

Dr. Feulner, a board-certified ophthalmologist, founded Advanced Eye Care & Aesthetics located in Bel Air, Md., in November 2003. She will become Ophthalmology Management’s first female chief medical editor.

Dr. Feulner received her MD and PhD from the University of Rochester School of Medicine and Dentistry, where she attended as part of the prestigious Medical Scientist Training Program. She completed her residency in ophthalmology at the University of Minnesota, where she was a chief resident. Recognized for her work as a comprehensive ophthalmologist and cataract/refractive surgeon, she is also well known for her expertise in invasive and non-invasive aesthetic services and is an original member of CEDARS ASPENS, a not-for-profit society of anterior segment surgeon educators.

“We’re excited to have Dr. Feulner with us at the editorial helm of Ophthalmology Management,” says Mr. Parry. “She has a great passion for our publication and brings a successful background of practice building and patient care expertise that will help OM grow its leadership position.” OM

QUICK NOTES

The FDA approved iCare USA’s EIDON Ultra-Widefield Lens module. The Ultra-Widefield module enables the capture of 120˚ images of the retina in a single shot or up to 200˚ with its expanded “Mosaic” function. The Ultra-Widefield lens is the newest accessory for the EIDON family of retinal imaging modalities. The module can be retrofitted to most of the EIDON fundus imaging systems, enabling the acquisition of Ultra-Widefield infrared, autofluorescence and fluorescein angiography images with an up to 200˚ panoramic view.

M&S Technologies announced a new enhancement, the DVA-5000, to its Clinical Trial Suite (CTS). The DVA-5000 is a dedicated product that specifically addresses the needs of glaucoma and retina trial sponsors and researchers, and the automated-testing protocols used by it are designed to be more efficient and accurate compared to traditional testing methods. CTS test results are automatically calculated and ready for review as letter score, logMAR, decimal score and Snellen equivalent. Secure reports are immediately available in XML or CSV format for export to any EDC, Reading Center or other location of choice.

Marco Ophthalmics is collaborating with HOYA Vision Care to provide customized offers tailored to the needs of each independent eye-care practitioner. Through this program, eye-care practitioners will receive complete complimentary consultations in both the technology and lens spaces, program discounts and support from both Marco and HOYA Vision Care. Those interested in learning more about the program can do so at info.hoyavision.com/marco-hoya-inquiries .

BVI has invested in Beyeonics Vision, developer of the Beyeonics One ophthalmic digital imaging system. The collaboration is intended to promote a streamlined process to commercialize Beyeonics One in the United States, with potential for rapid expansion in territories outside of the United States. Beyeonics One is an open and upgradable digital visualization platform, equipped with an ultra-high-resolution camera that processes and transfers digitally enhanced images to a high-resolution, head-wearable display for an immersive and natural stereoscopic 3D viewing experience.

PentaVision